Title : Effect of initial combination therapy with sitagliptin, a dipeptidyl peptidase-4 inhibitor, and pioglitazone on glycemic control and measures of beta-cell function in patients with type 2 diabetes - Yoon_2011_Int.J.Clin.Pract_65_154 |
Author(s) : Yoon KH , Shockey GR , Teng R , Golm GT , Thakkar PR , Meehan AG , Williams-Herman DE , Kaufman KD , Amatruda JM , Steinberg H |
Ref : Int J Clin Pract , 65 :154 , 2011 |
Abstract : |
PubMedSearch : Yoon_2011_Int.J.Clin.Pract_65_154 |
PubMedID: 21235696 |
Title : Sitagliptin: review of preclinical and clinical data regarding incidence of pancreatitis - Engel_2010_Int.J.Clin.Pract_64_984 |
Author(s) : Engel SS , Williams-Herman DE , Golm GT , Clay RJ , Machotka SV , Kaufman KD , Goldstein BJ |
Ref : Int J Clin Pract , 64 :984 , 2010 |
Abstract : |
PubMedSearch : Engel_2010_Int.J.Clin.Pract_64_984 |
PubMedID: 20412332 |
Title : Effect of initial combination therapy with sitagliptin, a dipeptidyl peptidase-4 inhibitor, and metformin on glycemic control in patients with type 2 diabetes - Goldstein_2007_Diabetes.Care_30_1979 |
Author(s) : Goldstein BJ , Feinglos MN , Lunceford JK , Johnson J , Williams-Herman DE |
Ref : Diabetes Care , 30 :1979 , 2007 |
Abstract : |
PubMedSearch : Goldstein_2007_Diabetes.Care_30_1979 |
PubMedID: 17485570 |